Archive Newsletter
-
03.07.26 -- Navigating Conflicting Raw Material Preferences With Your CDMO
3/7/2026
03/07/26
-
03.06.26 -- New Podcast Episodes: Therapeutic Power Of Fibroblasts, Curative Cell Therapies, Breakthrough HER2 Immunotherapy
3/6/2026
03/06/26 Cell & Gene Newsletter
-
03.06.26 -- Simplifying Friction In Cell Therapy Clinical Trials With Dr. Panteli Theocharous
3/6/2026
03/06/26 Cell & Gene Newsletter
-
03.05.26 -- Regulatory, Payer & Distribution Insights For CGT Success
3/5/2026
03/05/26 Cell & Gene Newsletter
-
03.05.26 -- Process Engineering's Key Role In Sterile Injectable Facility Design
3/5/2026
03/05/26 Cell & Gene Newsletter
-
03.04.26 -- Breaking Through Tumor Defenses With Next-Generation Cell Therapy
3/4/2026
03/04/26 Cell & Gene Newsletter
-
03.03.26 -- Inside Mesoblast's Playbook For Making Allogeneic Cell Therapy Real
3/3/2026
03/03/26
-
03.03.26 -- STREAM Edition: Breakthrough In HER2 Immunotherapy For PMO With Paul Romness
3/3/2026
03/03/26 Cell & Gene Newsletter
-
03.02.26 -- Navigating Conflicting Raw Material Preferences With Your CDMO
3/2/2026
03/02/26
-
02.27.26 -- Optimize Your Cell And Gene Therapy Manufacturing Workflows
2/27/2026
02/27/26 Cell & Gene Newsletter